Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6506cf133be42545d51d1490056f6af |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-64 |
filingDate |
1969-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1973-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347cb58c8d55cd4b2072d349a56e6172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34161ddf2fc456206248e2408e389dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_008eb6eb3725b5589702b1862e285e75 |
publicationDate |
1973-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-3709996-A |
titleOfInvention |
Pharmaceutical compositions containing n-cyclopropyl-1-aminoindane compounds and adapted for administration to obtain inhibition of monoamine oxidase enzyme and process |
abstract |
N-CYCLOPROPYL-1-AMINOINDANE COMPOUNDS ARE PROVIDED WHICH ACT AS INHIBTORS OF MONOAMINE OXIDASE IN THE ANIMAL BODY AND ALSO HAVE ADRENOLYTIC ACTIVITY. A PROCESS OF INHIBTING THE ACTION OF MONOAMINE OXIDASE ENZYME IS ALSO PROVIDED, IN WHICH SUCH COMPOUNDS ARE ADMINISTERED, AND PHARMACEUTICAL COMPOSITIONS IN DOSAGE UNIT FORM CONTAINING SUCH COMPOUNDS ARE PROVIDED FOR THIS PURPOSE. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6538025-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420696-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5877218-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5877221-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6271263-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880159-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625946-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609719-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6462222-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007293583-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4792628-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5914349-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010093848-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004010038-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007203232-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009131535-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6528685-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3407842-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6737547-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39616-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5994408-A |
priorityDate |
1963-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |